Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06786780 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids

Study acronym: ECCO
StatusEnrolling by Invitation
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 26, 2025 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
This is a single-arm, single-center, open-label, Phase II study aimed at assessing the efficacy of organoids in predicting the response to radiotherapy and chemotherapy in cervical cancer
Trial Details
NCT Number NCT06786780
Lead Sponsor Chongqing University Cancer Hospital
Conditions
(from sponsor)		 Cervical Cancer Treated with Pelvic Radiotherapy, Cervical Cancers
Related terms Uterine Cervical Neoplasms
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov